HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain

Intrathecal delivery of histone deacetylase inhibitors ameliorates hypersensitivity in models of neuropathic pain. This effect may be mediated at the level of the spinal cord through inhibition of HDAC1 function.